Trials / Completed
CompletedNCT04210232
Post-market Study to Obtain Surgeon Feedback on Clinical Outcome in Eyes Implanted With TECNIS Toric II IOL
Post-market Evaluation of Surgeon Feedback on TECNIS® TORIC II Intraocular Lens (IOL)
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 54 (actual)
- Sponsor
- Johnson & Johnson Surgical Vision, Inc. · Industry
- Sex
- All
- Age
- 22 Years
- Healthy volunteers
- Not accepted
Summary
This is a multicenter, prospective, single-arm, open-label, clinical study of the commercially available TECNIS Toric II, Model ZCU IOL. The study will be conducted in up to 1100 subjects enrolled with 1,000 subjects needing unilateral or bilateral cataract surgery across up to 50 US study sites.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | TECNIS® TORIC II Intraocular Lens (IOL) | Surgeons will perform standardized, small-incision, cataract surgery and implant in one or both eyes the study lenses. |
Timeline
- Start date
- 2020-01-14
- Primary completion
- 2020-09-11
- Completion
- 2020-09-11
- First posted
- 2019-12-24
- Last updated
- 2021-10-12
- Results posted
- 2021-10-12
Locations
12 sites across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT04210232. Inclusion in this directory is not an endorsement.